In vivo antitumoral activity of 5- (N-carbobenzyloxyamino) -1,4-naphthoquinone
Riondel, J.; Jacrot, M.; Beriel, H.; Chigr, M.; Fillion, H.
Die Pharmazie 46(2): 148-149
1991
ISSN/ISBN: 0031-7144 PMID: 1852772 Document Number: 385341
Document emailed within 1 workday
Related Documents
Firket, H.; Schaaf-Lafontaine, N. 1978: Cytotoxic activity in the course of antitumoral cellular immunity Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 133(7): 389-401Németh, L.; Somfai-Relle, S.; Kellner, B.; Sugár, J.; Bognár, R.; Farkas, J.; Bálint, J.; Pályi, I.; Tóth, K.; Szentirmay, Z.; Somosy, Z.; Pokorny, E. 1978: Study of the antitumoral activity of S-carbamoyl-L-cysteine derivatives in animal experiments Arzneimittel-Forschung 28(7): 1119-1123
Masquelier, M.; Vitols, S.; Peterson, C. 1986: Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice Cancer Research 46(8): 3842-3847
Ma, X.; Yin, X.; Liu, H.; Chen, Q.; Feng, Y.; Ma, X.; Liu, W. 2019: Antiproliferative activity of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) in human gastric carcinoma cells is facilitated via activation of autophagic pathway, mitochondrial-mediated programmed cell death and inhibition of cell migration and invasion Journal of BUON: Official Journal of the Balkan Union of Oncology 24(5): 2000-2005
Engers, H.D.; Sorenson, G.D.; Terres, G.; Horvath, C.; Brunner, K.T. 1982: Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells Journal of Immunology 129(3): 1292-1298
Mattu, S.; Dhar, S.K.; Sindhwani, S.K.; Ray, N.K. 1996: Analgesic efficacy of two derivatives of O-hydroxy-naphthoquinone Indian Journal of Physiology and Pharmacology 40(1): 103-104
Heicappell, R.; Ackermann, R. 1992: Renal carcinoma (RC): regulation of antitumoral immune responses Progress in Clinical and Biological Research 378: 207-216
Laborit, H.; Baron, C. 1971: Effects of monosemicarbazone of beta naphthoquinone in experimental hemorrhagic shock Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 12(1): 25-30
Winterfeld, K.; Wildersohn, M. 1970: Syntheses of 6-alkyl- or aralkyl-5,7-dioxo-2,3-pyrido- and 2,3-naphthoquinone-1,4-diazepines Pharmaceutica Acta Helvetiae 45(2): 323-327
da Silva, P.Bento.; Machado, R.Temperani.Amaral.; Pironi, A.Maria.; Alves, R.Carolina.; de Araújo, P.Rocha.; Dragalzew, A.Cutrim.; Dalberto, I.; Chorilli, M. 2019: Recent Advances in the Use of Metallic Nanoparticles with Antitumoral Action - Review Current Medicinal Chemistry 26(12): 2108-2146
Soltau, J.; Zirrgiebel, U.; Esser, N.; Schächtele, C.; Totzke, F.; Unger, C.; Merfort, I.; Drevs, J. 2008: Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model Anticancer Research 28(2a): 933-941
Ismaiel, S.A. 1976: A note on the colour reaction between piperazine and the sodium salt of 1.2-naphthoquinone-4-sulphonic acid Die Pharmazie 31(1): 52
Lima-Gonçalves, E.; Waitzberg, D.L.; Cologni, A.M.; Auricchio, M.T.; Bevilacqua, L.R.; Goffi, F.S. 1989: Influences of antitumoral chemotherapy on body composition and nitrogen balance: experimental study Revista do Hospital das Clinicas 44(1): 1-6
Levin, G.S.; Tremasova, G.I.; Kostova, S.V.; Dregeris, I.I. 1989: The mechanism of action of a synthetic derivative of 1,4-naphthoquinone on the respiratory chain of liver and heart mitochondria Biokhimiia 54(10): 1630-1637
Dumont, S.; Mabondzo, A.; Hartmann, D.; Gilgenkrantz, J.L.; Kessler, R.; Poindron, P.; Bartholeyns, J. 1990: Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release Anticancer Research 10(4): 949-954
Kalechman, Y.; Shani, A.; Dovrat, S.; Whisnant, J.K.; Mettinger, K.; Albeck, M.; Sredni, B. 1996: The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma Journal of Immunology 156(3): 1101-1109
Copeland, R.L.; Das, J.R.; Bakare, O.; Enwerem, N.M.; Berhe, S.; Hillaire, K.; White, D.; Beyene, D.; Kassim, O.O.; Kanaan, Y.M. 2007: Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines Anticancer Research 27(3b): 1537-1546
Konev, S.V.; Sukhodolets, I.G.; Volotovskiĭ, I.D.; Titovets, E.P. 1982: The structural membrane control of the reduction of exogenous quinones catalysed by mitochondrial 2-methyl-1,4-naphthoquinone reductase Molekuliarnaia Biologiia 16(6): 1279-1283
Ebbesen, P.; Olsson, L.; Rudkobing, O.; Haahr, S.; Kristensen, G. 1977: Correlation of in vivo cancer, net outer charge, in vitro migration, interferon activity, in vitro growth rates, and chalone-like activity to transformation-reversion in cloned Moloney and Kristen sarcoma virus-transformed mouse 3T3 cells Cancer Research 37(12): 4285-4290
Durnev, A.D.; Tiurina, L.S.; Guseva, N.V.; Oreshchenko, A.V.; Seredinin, S.B. 1997: Anticlastogenic activity of apo-carotene in vivo Eksperimental'naia i Klinicheskaia Farmakologiia 60(3): 68-70